The analysis revealed that the expression of SLC39A1, SLC39A4, and SLC39A8 is tightly associated with the prognosis of LIHC, CESC, PAAD, and KIRP, respectively. This evidence concerns the gene SLC39A1 and pancreatic adenocarcinoma.